January 2003

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Conditions:   Leukemia;   Lymphoma;   Multiple Myeloma;   Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myeloproliferative Neoplasms
Interventions:   Biological: anti-thymocyte globulin;   Biological: G-CSF;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic cell transplantation;   Drug: allopurinol
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Completed - verified June 2016